Additional value of PCA3 density to predict initial prostate biopsy outcome

被引：0
|
作者：
A. Ruffion
P. Perrin
M. Devonec
D. Champetier
M. Decaussin
P. Paparel
V. Vlaeminck-Guillem
机构：
[1] Hospices Civils de Lyon,Service d’Urologie, Centre Hospitalier Lyon Sud
[2] Université de Lyon,Faculté de Médecine
[3] Université Claude Bernard Lyon 1,Institut de Génomique Fonctionnelle de Lyon, CNRS UMR5242
[4] Université de Lyon,Service d’Anatomie et de Cytologie Pathologiques, Centre Hospitalier Lyon Sud
[5] Université Lyon 1,Unité Médicale d’Oncologie Moléculaire et Transfert, Service de Biochimie biologie moléculaire sud, Centre Hospitalier Lyon Sud
[6] Hospices Civils de Lyon,Centre de Recherche en Cancérologie de Lyon
[7] Hospices Civils de Lyon, INSERM 1052 CNRS 5286
[8] Centre Léon Bérard,undefined
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Prostate cancer; Tumor markers; Urine; PSA; PSA density; Prostate cancer gene 3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：917 / 923
页数：6
相关论文
共 50 条
  • [41] Value of PCA3 urinary test for prostate biopsy decision: the Lyon-Sud University Hospital experience
    Vlaeminck-Guillem, Virginie
    Campos-Fernandes, Jean-Louis
    Champetier, Denis
    Chikh, Karim
    Decaussin-Petrucci, Myriam
    Devonec, Marian
    Gobeaux, Nicolas
    Paparel, Philippe
    Perrin, Paul
    Rodriguez-Lafrasse, Claire
    Ruffion, Alain
    ANNALES DE BIOLOGIE CLINIQUE, 2011, 69 (01) : 31 - 39
  • [42] PCA3 REPRESENTS A CLINICALLY MEANINGFUL PREDICTOR OF PROSTATE CANCER AT REPEAT BIOPSY
    Haese, A.
    Chun, F.
    de la Taille, A.
    van Poppel, H.
    Marberger, M.
    Mulders, P.
    Abbou, C. -C.
    Stenzl, A.
    Huland, H.
    Tinzl, M.
    Remzi, M.
    Feyerabend, S.
    Van Gils, M.
    Stillebroer, A.
    Schalken, J.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4053 - 4054
  • [43] Prostate cancer 3 (PCA3) represents a clinically meaningful predictor of prostate cancer at repeat biopsy
    Haese, Alexander
    Chun, Felix K. H.
    de la Taille, Alexandre
    van Poppel, Hendrik
    Marberger, Michael
    Mulders, Peter F.
    Abbou, Clement-Claude C.
    Stenzl, Amulf
    Huland, Hartwig
    Tinzl, Martina
    Remzi, Mesut
    Feyerabend, Suzan
    Van Gils, Martijn
    Stillebroer, Alexander
    Schalken, Jack A.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 724 - 725
  • [44] Utility of PCA3 Urine Assay in Japanese Men Undergoing Prostate Biopsy
    Ochiai, A.
    Okihara, K.
    Kamoi, K.
    Shimazui, T.
    Oikawa, T.
    Tomita, K.
    Murayama, S.
    Umekawa, T.
    Uemura, H.
    Miki, T.
    UROLOGY, 2012, 80 (03) : S102 - S103
  • [45] HEAD-TO-HEAD COMPARISON OF PROSTATE HEALTH INDEX AND URINARY PCA3 ASSAY IN PREDICTING PROSTATE CANCER AT INITIAL OR REPEAT PROSTATE BIOPSY
    Scattoni, Vincenzo
    Lazzeri, Massimo
    De Luca, Stefano
    Passera, Roberto
    Bollito, Enrico
    Randone, Donato
    Abdollah, Firas
    Capitanio, Umberto
    Maccagnano, Carmen
    Lughezzani, Giorgio
    Lista, Giuliana
    Gadda, Giulio Maria
    Larcher, Alessandro
    Montorsi, Francesco
    Guazzoni, Giorgio
    JOURNAL OF UROLOGY, 2013, 189 (04): : E912 - E912
  • [46] PCA3 COMPARISON WITH PROSTATE HEALTH INDEX (PHI) IN REPEAT BIOPSY PATIENTS
    Perdona, Sisto
    Ferro, Matteo
    Perruolo, Giuseppe
    Formisano, Pietro
    Portella, Giuseppe
    Badi, Ermanno
    Longo, Michele
    Di Lorenzo, Giuseppe
    Autorino, Riccardo
    Altieri, Vincenzo
    Terracciano, Daniela
    ANTICANCER RESEARCH, 2011, 31 (05) : 1918 - 1918
  • [47] PCA3 represents a clinically meaningful predictor of prostate cancer at repeat biopsy
    Haese, A.
    Chun, F.
    De La Taille, A.
    Van Poppel, H.
    Marberger, M.
    Mulders, P.
    Abbou, C. C.
    Stenzl, A.
    Huland, H.
    Tinzi, M.
    Remzi, M.
    Feyeralbend, S.
    Van Gils, M.
    Stillebroer, A.
    Schalken, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 140 - 140
  • [48] PROSTATE BIOPSY: PATHOLOGICAL PATTERNS IN MEN WITH PROSTATE CANCER GENE 3 (PCA3) SCORE FLUCTUATIONS
    De Luca, Stefano
    Passera, Roberto
    Bollito, Enrico
    Cappia, Susanna
    Amparore, Daniele
    Cattaneo, Giovanni
    Manfredi, Matteo
    Mele, Fabrizio
    Bertolo, Riccardo
    Porpiglia, Francesco
    ANTICANCER RESEARCH, 2015, 35 (06) : 3723 - 3723
  • [49] Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
    Scattoni, Vincenzo
    Lazzeri, Massimo
    Lughezzani, Giovanni
    De Luca, Stefano
    Passera, Roberto
    Bollito, Enrico
    Randone, Donato
    Abdollah, Firas
    Capitanio, Umberto
    Larcher, Alessandro
    Lista, Giuliana
    Gadda, Giulio Maria
    Bini, Vittorio
    Montorsi, Francesco
    Guazzoni, Giorgio
    JOURNAL OF UROLOGY, 2013, 190 (02): : 496 - 501
  • [50] INITIAL SCREENING USING PCA3 WITH PSAD IMPROVED PROSTATE CANCER DETECTION
    Fazzari, Melissa J.
    Salcedo, Jose M.
    Gildersleeve, Roy T.
    Werneburg, Glenn T.
    Le Sueur, Amanda L.
    Schiff, Jeffrey T.
    Corcoran, Anthony T.
    Katz, Aaron E.
    JOURNAL OF UROLOGY, 2018, 199 (04): : E609 - E610
12345